Posted on 10/22/19
Sverica Capital Management Announces Investment in In Vitro Sciences
Sverica Capital Management LP), a private equity investment firm, today announced that on October 1st it made a strategic investment in In Vitro Sciences LLC, which . . .
Posted on 10/21/19
CRISPR Therapeutics and Bayer Announce an Update on Casebia Therapeutics
CRISPR Therapeutics and Bayer today announced proposed plans whereby Casebia Therapeutics, a joint venture between CRISPR Therapeutics and Bayer, would operate under the direct management of . . .
Posted on 10/21/19
Charles River Laboratories Announces Offering of $500 Million of Senior Notes
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it intends to offer $500 million in aggregate principal amount of senior notes due . . .
Posted on 10/21/19
Verseau Launches with $50 Million
Verseau Therapeutics, Inc. launched today with $50 million in financing from 20/20 HealthCare Partners, 3SBio, Alexandria Venture Investments, Highlight Capital, InHarv Partners Ltd.,
Posted on 10/20/19
Arch Therapeutics Announces $2.5 Million Registered Direct Offering
FRAMINGHAM, Mass., Oct. 17, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and . . .
Posted on 10/20/19
Rhythm Pharmaceuticals Prices Public Offering
BOSTON, Oct. 15, 2019 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of . . .
Posted on 10/17/19
Clearsight Advises West Monroe Partners on its Acquisition of GoKart Labs
Clearsight Advisors, Inc. is pleased to announce another successful transaction in its Digital Transformation practice.
Posted on 10/17/19
NeuroMetrix Reports Q3 2019 Financial Results
WOBURN, Mass., Oct. 17, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended September 30, 2019.The Company . . .
Posted on 10/17/19
Berkshire Hathaway: The Forest Is Selling At A Discount
SummaryTo value Berkshire Hathaway, we look no further than Warren Buffett’s 2018 annual letter to shareholders.For the first time, Buffett specifically detailed how he values Berkshire . . .
Posted on 10/16/19
CVS Health Announces $2.5 Million in New Funding
As part of its commitment to building healthier communities, CVS Health (NYSE: CVS) today announced it and its private charity will be donating more than $2.5 . . .
Posted on 10/16/19
Onduo named as a Finalist for Mass Technology Leadership Council Award for Digital Transformation in Healthcare
BOSTON--(BUSINESS WIRE)--Massachusetts’ leading technology industry association recently announced finalists for the 2019 Mass Tech Leadership Awards. The 16 award categories highlight the vitality, innovation and importance . . .
Posted on 10/15/19
Cyteir Therapeutics Secures Additional $40.2 Million in Its Series B Financing
Cyteir Therapeutics, a leader in the discovery and development of next-generation synthetic lethal therapies for cancer
Posted on 10/15/19
CRISPR Therapeutics and KSQ Therapeutics Announce License Agreement
ZUG, Switzerland & CAMBRIDGE, Mass.--(BUSINESS WIRE)--CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and KSQ Therapeutics, a biotechnology . . .
Posted on 10/15/19
Is This What's Holding Berkshire Hathaway Stock Back?
Warren Buffett has been at the helm of Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) for decades, and his track record there makes him one of the most successful . . .
Posted on 10/11/19
T2 Biosystems Reports Granting of Inducement Awards
LEXINGTON, Mass., Oct. 11, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical . . .
Posted on 10/11/19
Better Buy: Biogen vs. Gilead Sciences
Biogen (NASDAQ:BIIB) and Gilead Sciences (NASDAQ:GILD) are both biotech royalty. In the not-so-distant past, these two top biotech stocks clobbered the broader markets in terms of . . .
Posted on 10/9/19
Aprea Therapeutics Closes IPO
BOSTON, Oct. 07, 2019 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (NASDAQ: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutant . . .
Posted on 10/9/19
bluebird bio and Novo Nordisk Enter into Research Agreement
CAMBRIDGE, Mass. and BAGSVÆRD, Denmark--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) and Novo Nordisk A/S (NVO) today announced that they have entered into a research collaboration to . . .
Posted on 10/9/19
IM Therapeutics Closes $10 Million Financing
ImmunoMolecular Therapeutics, a clinical stage company developing personalized therapies for autoimmune disease, today announced that it has raised $10 million in Series A financing
Posted on 10/9/19
3 Reasons Vertex Pharmaceuticals Is Poised for a Big Year
Investing in biotechnology stocks can sometimes feel more like gambling than serious wealth-building. Company success usually rides on the binary events of clinical trials and regulatory . . .
Posted on 10/8/19
DFLabs Awarded with Two U.S. Patents for Its Pioneering SOAR Technology
BOSTON--(BUSINESS WIRE)--DFLabs, the award-winning Security Orchestration, Automation and Response (SOAR) vendor, today announced it has been awarded two patents by the United States Patent and Trademark . . .
Posted on 10/8/19
Datavant Collaborates with Boston University
Datavant, the leader in helping healthcare organizations connect and share health data, today announced that it will be a founding member of the Boston University (BU) . . .
Posted on 10/8/19
Copyright Clearance Center Announces RightsLink for Scientific Communications
DANVERS, Mass.--(BUSINESS WIRE)--Copyright Clearance Center, Inc. (CCC), a leader in advancing copyright, accelerating knowledge, and powering innovation, announces the release of RightsLink® for Scientific Communications, formerly . . .
Posted on 10/8/19
Goldman Exits Marathon Health
WINOOSKI, Vt. & NEW YORK--(BUSINESS WIRE)--Marathon Health, a leading provider of employer health centers, and General Atlantic, a leading global growth equity firm, today announced a . . .
Posted on 10/8/19
Decibel Therapeutics to Provide Corporate Update
BOSTON--(BUSINESS WIRE)--Decibel Therapeutics, a clinical-stage biotechnology company developing novel therapeutics for hearing loss and balance disorders, will provide a corporate update at the upcoming Jefferies Gene . . .

